While 2HG is a specific, and thus, a highly valuable marker of IDH‐mutated gliomas, quantifying anything other than the ratio of Cho/NAA is difficult in a clinical setup without MRS experts, as decisions on acquisition, signal processing, and fitting of resonance peaks affect the results to a greater degree than in conventional MRI. The gene discussed is IDH1; the disease is glioma.